Recombinant Human Osteoprotegerin/Fc Chimera (rHuOPG-Fc)
Selected Variant
GTR18991717-01
Size: 1 mg
Osteoprotegerin (OPG) is a member of the TNFR superfamily that can act as a decoy receptor for RANKL. Binding of soluble OPG to sRANKL inhibits osteoclastogenesis by interrupting the signaling between stromal cells and osteoclastic progenitor cells, thereby leading to excess accumulation of bone and cartilage. OPG is expressed in a wide variety of tissues including adult heart, lung, kidney, liver, spleen, prostate, lymph node and bone marrow. OPG is secreted both as a monomeric and a dimeric protein. Its primary structure consists of seven distinct domains, four of which corresponds to the extracellular cysteine-rich domains of TNFR proteins and constitutes the soluble OPG.
Product Specifications
Source
Pichia. Pastoris.
Endotoxin
Less than 1EU/g of rHuOPG-Fc as determined by LAL method.
Purity
>90% by SDS-PAGE and HPLC analyses.
Bioactivity
Form
Lyophilized from a 0.2m filtered concentrated solution in PBS, pH 7.4.
Molecular Weight
Storage Conditions
Notes
For research use only.
Applications Notes
Preservative
Lyophilized from a 0.2m filtered concentrated solution in PBS, pH 7.4.
AA Sequence
Available Sizes
Price
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog